PL2214021T3 - Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym - Google Patents

Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym

Info

Publication number
PL2214021T3
PL2214021T3 PL10162987T PL10162987T PL2214021T3 PL 2214021 T3 PL2214021 T3 PL 2214021T3 PL 10162987 T PL10162987 T PL 10162987T PL 10162987 T PL10162987 T PL 10162987T PL 2214021 T3 PL2214021 T3 PL 2214021T3
Authority
PL
Poland
Prior art keywords
kit
csf
implantation success
assisted fertilisation
predicting
Prior art date
Application number
PL10162987T
Other languages
English (en)
Inventor
Nathalie Lédée
Marie-Pierre Piccinni
Raoul Lombroso
Original Assignee
Femalon S P R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Femalon S P R L filed Critical Femalon S P R L
Publication of PL2214021T3 publication Critical patent/PL2214021T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL10162987T 2006-07-21 2007-07-18 Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym PL2214021T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83209406P 2006-07-21 2006-07-21
EP07787688A EP2049906B1 (en) 2006-07-21 2007-07-18 Assay and kit for predicting implantation success in assisted fertilisation
EP10162987.1A EP2214021B1 (en) 2006-07-21 2007-07-18 Kit for predicting implantation success in assisted fertilisation

Publications (1)

Publication Number Publication Date
PL2214021T3 true PL2214021T3 (pl) 2015-06-30

Family

ID=38529962

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07787688T PL2049906T3 (pl) 2006-07-21 2007-07-18 Test i zestaw do przewidywania powodzenia zagnieżdżenia zarodka we wspomaganym zapłodnieniu
PL10162987T PL2214021T3 (pl) 2006-07-21 2007-07-18 Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL07787688T PL2049906T3 (pl) 2006-07-21 2007-07-18 Test i zestaw do przewidywania powodzenia zagnieżdżenia zarodka we wspomaganym zapłodnieniu

Country Status (20)

Country Link
US (1) US8211650B2 (pl)
EP (5) EP3627156A1 (pl)
JP (1) JP5052609B2 (pl)
KR (2) KR101482568B1 (pl)
CN (2) CN101495871A (pl)
AT (1) ATE468538T1 (pl)
AU (1) AU2007275112B2 (pl)
BR (1) BRPI0714494B1 (pl)
CA (1) CA2658665C (pl)
DE (1) DE602007006672D1 (pl)
DK (2) DK2214021T3 (pl)
EA (1) EA016348B1 (pl)
ES (4) ES2531853T3 (pl)
HR (2) HRP20100382T8 (pl)
MX (1) MX2009000569A (pl)
MY (1) MY150687A (pl)
NZ (1) NZ574135A (pl)
PL (2) PL2049906T3 (pl)
PT (2) PT2049906E (pl)
WO (1) WO2008009705A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1682074T3 (da) 2003-10-24 2012-05-29 Nora Therapeutics Inc Præparater og fremgangsmåder til sund graviditet
US8338373B2 (en) 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
US9176145B2 (en) 2006-07-21 2015-11-03 Femalon S.P.R.L. Kit for predicting implantation success in assisted fertilization
GB0806281D0 (en) * 2008-04-07 2008-05-14 Univ Leeds Markers of Oocyte viability
CA2720651C (en) * 2008-05-01 2020-03-10 Zymogenetics, Inc. Levels of blys/april heterotrimers in serum and use in diagnostic methods
WO2010126528A1 (en) * 2009-05-01 2010-11-04 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
EP2446251B1 (en) * 2009-06-25 2018-12-05 Phase Holographic Imaging Phi AB Analysis of ova or embryos with digital holographic imaging
WO2011000805A1 (en) 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
US9753042B2 (en) * 2013-04-23 2017-09-05 Rosalind Franklin University Of Medicine And Science Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
JP6470178B2 (ja) * 2013-07-29 2019-02-13 株式会社プロトセラ 卵子の受精可能性の検査のためのバイオマーカーおよびそれを用いた判定
CA2948039C (en) * 2014-04-02 2023-07-25 Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research A prognostic assay for success of assisted reproductive technology
CN104450904A (zh) * 2014-12-02 2015-03-25 柳州市妇幼保健院 利用颗粒细胞端粒长度来判断胚胎发育潜能的方法
CN108450005A (zh) * 2015-09-30 2018-08-24 哈德逊医学研究所 一种治疗和预后方法
CN110361534B (zh) * 2018-03-26 2023-11-03 山大生殖研发中心有限公司 评估胚胎和预测体外受精成功率的化学标记物和其应用
RU2746644C1 (ru) * 2021-01-21 2021-04-19 Мекан Рахимбердыевич Оразов Способ оценки имплантационной состоятельности эндометрия при повторных неудачах имплантации, ассоциированных с хроническим эндометритом

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
KR900700170A (ko) 1988-03-24 1990-08-11 원본미기재 파라로그 어피니티 크로마토그라피
JP3058673B2 (ja) * 1989-11-10 2000-07-04 株式会社明電舎 サイトカインの測定方法及びその測定用キット
GB9603326D0 (en) 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
JP5271481B2 (ja) * 1999-09-08 2013-08-21 中外製薬株式会社 タンパク質溶液製剤およびその安定化方法
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
KR100961859B1 (ko) 2001-07-11 2010-06-09 맥시겐 홀딩스 엘티디 지-씨에스에프 접합체

Also Published As

Publication number Publication date
ES2754707T3 (es) 2020-04-20
CN106199004B (zh) 2019-04-09
HK1208529A1 (en) 2016-03-04
JP5052609B2 (ja) 2012-10-17
BRPI0714494B1 (pt) 2018-05-08
EP3267198A1 (en) 2018-01-10
EP2857840B8 (en) 2017-08-02
BRPI0714494A2 (pt) 2013-05-14
DK2049906T3 (da) 2010-07-05
EP3267198B1 (en) 2019-09-04
EP2857840A1 (en) 2015-04-08
EP2214021A1 (en) 2010-08-04
NZ574135A (en) 2011-11-25
KR20140040289A (ko) 2014-04-02
HRP20100382T1 (hr) 2010-08-31
US20090312596A1 (en) 2009-12-17
EP2214021B1 (en) 2015-01-07
ES2345571T3 (es) 2010-09-27
EP2049906A1 (en) 2009-04-22
DK2214021T3 (en) 2015-02-16
WO2008009705A1 (en) 2008-01-24
EA016348B1 (ru) 2012-04-30
CN106199004A (zh) 2016-12-07
MY150687A (en) 2014-02-28
PT2214021E (pt) 2015-03-11
KR20090056986A (ko) 2009-06-03
EP2049906B1 (en) 2010-05-19
PT2049906E (pt) 2010-08-02
EA200900210A1 (ru) 2009-06-30
ATE468538T1 (de) 2010-06-15
DE602007006672D1 (de) 2010-07-01
CA2658665A1 (en) 2008-01-24
PL2049906T3 (pl) 2010-10-29
EP3627156A1 (en) 2020-03-25
CN101495871A (zh) 2009-07-29
ES2531853T3 (es) 2015-03-20
KR101482568B1 (ko) 2015-01-14
AU2007275112B2 (en) 2012-07-12
EP2857840B1 (en) 2017-06-14
CA2658665C (en) 2017-09-26
HRP20150251T1 (en) 2015-06-05
JP2009544934A (ja) 2009-12-17
AU2007275112A1 (en) 2008-01-24
US8211650B2 (en) 2012-07-03
HRP20100382T8 (hr) 2010-10-31
MX2009000569A (es) 2009-06-19
ES2634527T3 (es) 2017-09-28
HK1128760A1 (en) 2009-11-06

Similar Documents

Publication Publication Date Title
HRP20150251T1 (en) Kit for predicting implantation success in assisted fertilisation
EA201101141A1 (ru) Получение закрытой линейной днк
WO2014132244A9 (en) Maternal plasma transcriptome analysis by massively parallel rna sequencing
BR112015022821A2 (pt) método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico
MY180473A (en) Imaging and evaluating embryos, oocytes, and stem cells
NZ630356A (en) Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
EP2657697A3 (en) Methods for determining the risk of chromosomal abnormality in a fetus
AR085702A1 (es) Metodos para predecir el rendimiento en plantas y aplicaciones de uso de los mismos
WO2009125219A3 (en) Markers of oocyte viability
WO2014155105A3 (en) Assessment of risk of aneuploidy
MX2012005388A (es) Reactivos y metodos para detectar globulos blancos pnh tipo ii y su identificacion como factores de riesgo para transtornos trombolicos.
Asensio et al. Coupling stabilized finite element methods with finite difference time integration for advection–diffusion–reaction problems
Tessaro et al. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte fertilization test
WO2010045323A3 (en) A novel sorting technology that allows for highly efficient selection of sperm without chromatin damage
BR112017007213A2 (pt) "processamento e utilização de fluidos do trato reprodutivo para melhorar a produção in vitro de embriões de mamífero"
EP1790355A4 (en) PROPAGATING AGENTS AND PROPAGATION PROCESSES FOR NATURAL KILLER CELL
Roccheri et al. Cellular, biochemical and molecular effects of cadmium on marine invertebrates: Focus on Paracentrotus lividus sea urchin development
Ferenčaković et al. Genomic analysis of inbreeding depression: Lessons from bull fertility traits
Morbeck et al. PP-24 DEVELOPMENT OF HYBRID MURINE ZYGOTES IN HTF: INTERACTION OF AIR QUALITY AND ENERGY METABOLISM
RU2013135071A (ru) Способ определения адгезивности клеток крови
PL399243A1 (pl) Sposób dostarczania próbki plynu ustrojowego do ukladu analizujacego
Todorova et al. Gene Panel in Human Cumulus Cells as Biomarker for Successful in vitro Procedures
UA50356U (ru) Способ определения качества лабораторных культур паразитических перепончатокрылых энтомофагов
Niinisto Happy memories